News

06.08.2022
According to published data, the production and business results of the second quarter of 2022 of Cuu Long Pharmaceutical Joint Stock Company (DCL) is recorded its accounting profit before tax of VND 33 billion, equivalent to 196% compared to the first quarter of 2022, its profit after tax of VND 26 billion, equivalent to 193% […]
15.06.2022
On the afternoon of June 14, another member of FIT Group, Cuu Long Pharmaceutical Joint Stock Company (DCL), held the Annual General Meeting of Shareholders AGM in 2022 to approve the production and business target strategy in 2022. 2021 – The year of overcoming difficulties of DCL In 2021, the Covid-19 epidemic re-emerged across the […]
01.06.2022
On May 21, at Ben Thanh Theater, Cuu Long Pharmaceutical Joint Stock Company (DCL) was honored to receive the award “Top 10 Vietnam Leading Brands 2022”. The award is a recognition for DCL’s continuous efforts during and after the pandemic, contributing to further affirming DCL’s position and reputation in the pharmaceutical field during more than […]
30.04.2022
Over 15 years of establishment and development, F.I.T Group Joint Stock Company has become a strong corporation playing the role of investment, capital management, and ownership in controlling companies operating in basic and essential industries. F.I.T Group’s total assets increased over 172 times after 15 years F.I.T Group owns many companies with total assets of […]
13.03.2022
A series of information related to the arrest of a former senior leader of the Ministry of Health and previously a former leader of Cuu Long Pharmaceutical Joint Stock Company (Cuu Long company, code DCL), the General Director of the Company said that these are legal issues of the old period, not related to the […]